Friedli A, Hunziker T, Finkel B, Braathen L R
Dermatological Clinic, Inselspital, University of Berne, Switzerland.
Arch Dermatol Res. 1993;285(1-2):1-5. doi: 10.1007/BF00370815.
Healthy volunteers (n = 14, age range 20-31 years, mean 23) were irradiated on the inside of the left forearm on four consecutive days with their individual minimal erythemal dose of ultraviolet B (UVB) prior to sensitization in the same skin area with a 2% solution of diphenylcyclopropenone (DPCP). The reaction patterns were compared with 14 alopecia areata patients (age range 16-69 years, mean 40) starting topical immunotherapy with DPCP, sensitized without prior UVB treatment. Primary allergic reactions occurred in ten volunteers and in four alopecia areata patients. Patch testing on the upper back with serial dilutions of DPCP (1% to 10(-8)%) showed minimal dermatitis-eliciting concentrations ranging from 1 to 10(-4)% (mean 0.19%) in the volunteers as compared with 10(-1) to 10(-8)% (mean 0.025%) in the alopecia areata patients. Two patterns were discernible within the volunteers with respect to the intensity of the primary allergic and elicitation reactions. Ten volunteers reacted in a similar way to the alopecia areata patients, whereas four probands demonstrated very high minimal dermatitis-eliciting concentrations and overall less severe reactions. The DPCP-specific T-cell response using blood macrophages and B lymphocytes as antigen-presenting cells was measured in an in vitro assay in two alopecia areata patients and two volunteers having similar skin reactions as well as in two volunteers with overall less severe skin reactions. B lymphocytes from the alopecia areata patients and the volunteers with similar skin reactions induced a significant DPCP-specific T-cell proliferation exceeding the responses obtained using macrophages.(ABSTRACT TRUNCATED AT 250 WORDS)
14名健康志愿者(年龄范围20 - 31岁,平均23岁)在左前臂内侧连续4天接受其个体最小红斑量的紫外线B(UVB)照射,然后在同一皮肤区域用2%二苯环丙烯酮(DPCP)溶液致敏。将反应模式与14名斑秃患者(年龄范围16 - 69岁,平均40岁)进行比较,这些斑秃患者开始用DPCP进行局部免疫治疗,未经过UVB预处理即致敏。10名志愿者和4名斑秃患者出现了初次过敏反应。在上背部用系列稀释的DPCP(1%至10⁻⁸%)进行斑贴试验,结果显示志愿者引发皮炎的最小浓度范围为1%至10⁻⁴%(平均0.19%),而斑秃患者为10⁻¹%至10⁻⁸%(平均0.025%)。就初次过敏反应和激发反应的强度而言,志愿者中可辨别出两种模式。10名志愿者的反应与斑秃患者相似,而4名受试者表现出非常高的引发皮炎的最小浓度且总体反应较轻。在体外试验中,以血液巨噬细胞和B淋巴细胞作为抗原呈递细胞,检测了两名斑秃患者、两名有相似皮肤反应的志愿者以及两名总体皮肤反应较轻的志愿者的DPCP特异性T细胞反应。来自斑秃患者和有相似皮肤反应的志愿者的B淋巴细胞诱导了显著的DPCP特异性T细胞增殖,超过了使用巨噬细胞获得的反应。(摘要截选于250字)